303 related articles for article (PubMed ID: 18208911)
1. Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze.
Pinheiro SN; Del-Ben CM; Zangrossi H; Graeff FG
J Psychopharmacol; 2008 Mar; 22(2):132-7. PubMed ID: 18208911
[TBL] [Abstract][Full Text] [Related]
2. Picrotoxin blocks the anxiolytic- and panicolytic-like effects of sodium valproate in the rat elevated T-maze.
Dombrowski PA; Fernandes LH; Andreatini R
Eur J Pharmacol; 2006 May; 537(1-3):72-6. PubMed ID: 16626689
[TBL] [Abstract][Full Text] [Related]
3. Reversible inactivation of the dorsal raphe nucleus blocked the antipanic-like effect of chronic imipramine in the elevated T-maze.
Dombrowski PA; Andreatini R
Neurosci Lett; 2006 Oct; 407(1):80-5. PubMed ID: 16959426
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic effects of a semipurified constituent of guaraná seeds on rats in the elevated T-maze test.
Roncon CM; Biesdorf de Almeida C; Klein T; de Mello JC; Audi EA
Planta Med; 2011 Feb; 77(3):236-41. PubMed ID: 20845263
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic effects of short- and long-term administration of cacao mass on rat elevated T-maze test.
Yamada T; Yamada Y; Okano Y; Terashima T; Yokogoshi H
J Nutr Biochem; 2009 Dec; 20(12):948-55. PubMed ID: 18976895
[TBL] [Abstract][Full Text] [Related]
6. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
[TBL] [Abstract][Full Text] [Related]
7. Contrasting effects of acute and chronic treatment with imipramine and fluoxetine on inhibitory avoidance and escape responses in mice exposed to the elevated T-maze.
Gomes KS; de Carvalho-Netto EF; Monte KC; Acco B; Nogueira PJ; Nunes-de-Souza RL
Brain Res Bull; 2009 Mar; 78(6):323-7. PubMed ID: 19047015
[TBL] [Abstract][Full Text] [Related]
8. Assessment of anxiolytic and panicolytic effects of dichloromethane fraction from stems of Kielmeyera coriacea.
Biesdorf C; Cortez DA; Audi EA
Phytomedicine; 2012 Feb; 19(3-4):374-7. PubMed ID: 21975171
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of 5-HT1A or 5-HT2A receptors in the ventrolateral periaqueductal gray causes anxiolytic-, but not panicolytic-like effect in rats.
de Paula Soares V; Zangrossi H
Behav Brain Res; 2009 Jan; 197(1):178-85. PubMed ID: 18801389
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray.
Lim LW; Blokland A; Tan S; Vlamings R; Sesia T; Aziz-Mohammadi M; Visser-Vandewalle V; Steinbusch HW; Schruers K; Temel Y
Exp Neurol; 2010 Dec; 226(2):293-300. PubMed ID: 20837005
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
Vicente MA; Zangrossi H
Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
[TBL] [Abstract][Full Text] [Related]
12. Dorsomedial hypothalamus serotonin 1A receptors mediate a panic-related response in the elevated T-maze.
Nascimento JO; Kikuchi LS; de Bortoli VC; Zangrossi H; Viana MB
Brain Res Bull; 2014 Oct; 109():39-45. PubMed ID: 25290207
[TBL] [Abstract][Full Text] [Related]
13. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze.
Bessa JM; Oliveira M; Cerqueira JJ; Almeida OF; Sousa N
Behav Brain Res; 2005 Jul; 162(1):135-42. PubMed ID: 15922074
[TBL] [Abstract][Full Text] [Related]
14. Effect of the acute and chronic estrogen on anxiety in the elevated T-maze.
Kalandakanond-Thongsong S; Daendee S; Srikiatkhachorn A
Physiol Behav; 2012 Jan; 105(2):357-63. PubMed ID: 21907223
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of acute sibutramine in female rats in the elevated T-maze and elevated plus-maze tests.
Santos RO; de Assunção GL; de Medeiros DM; de Sousa Pinto IA; de Barros KS; Soares BL; André E; Gavioli EC; de Paula Soares-Rachetti V
Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):181-7. PubMed ID: 24034271
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic-like effect of chronic treatment with Erythrina velutina extract in the elevated plus-maze test.
Raupp IM; Sereniki A; Virtuoso S; Ghislandi C; Cavalcanti E Silva EL; Trebien HA; Miguel OG; Andreatini R
J Ethnopharmacol; 2008 Jul; 118(2):295-9. PubMed ID: 18550307
[TBL] [Abstract][Full Text] [Related]
17. Panic-modulating effects of alprazolam, moclobemide and sumatriptan in the rat elevated T-maze.
Sant'Ana AB; Weffort LF; de Oliveira Sergio T; Gomes RC; Frias AT; Matthiesen M; Vilela-Costa HH; Yamashita PS; Vasconcelos AT; de Bortoli V; Del-Ben CM; Zangrossi H
Behav Brain Res; 2016 Dec; 315():115-22. PubMed ID: 27531502
[TBL] [Abstract][Full Text] [Related]
18. Infusion of galanin into the mid-caudal portion of the dorsal raphe nucleus has an anxiolytic effect on rats in the elevated T-maze.
Silote GP; Rosal AB; de Souza MM; Beijamini V
Behav Brain Res; 2013 Sep; 252():312-7. PubMed ID: 23791934
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide involvement and neural substrates of the conditioned and innate fear as evaluated in the T-maze test in rats.
Calixto AV; Duarte FS; Moraes CK; Faria MS; De Lima TC
Behav Brain Res; 2008 Jun; 189(2):341-9. PubMed ID: 18342958
[TBL] [Abstract][Full Text] [Related]
20. An approach to evaluate the ability of rats to discriminate different levels of illumination in the plus maze test: effects of scopolamine.
de Araújo Godinho MA; Meneghini L; Lucinda AM; Borges FR; Sakae DY; Marino Neto J; Paschoalini MA; de Lima TC; Faria MS
Behav Brain Res; 2007 Jun; 180(1):86-94. PubMed ID: 17408761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
